article · Integrated Environmental Assessment and Management
This review addresses the critical issue of antibiotics and antibiotic resistance genes (ARGs) in Nigerian water systems, which pose significant public health and environmental challenges. Reported antibiotic concentrations in Nigerian surface waters was a maximum of 272.15 μg/L, frequently exceeding the World Health Organization (WHO) recommended safety limit of 72 out of 75 antibiotics. Sulfonamides, beta-lactams, tetracyclines, fluoroquinolones, carbapenems, and cephalosporins are the most common classes of antibiotics detected, with residues reported in >80% of surface water studies. Many ARGs such as beta-lactamase (bla), tetracycline (tet), and sulfonamide (sul) genes have been found in 70%-90% of water sources in Nigeria, and they are also common in Ghana. The prevalence of these antibiotics and ARGs in Nigerian water sources are linked to human and animal activities, including medical facilities, pharmaceutical industries, and agricultural practices. These sources contribute to the widespread distribution of ARGs, which are exacerbated by inadequate wastewater treatment and regulatory policies. The persistence of these contaminants threatens aquatic ecosystems and human health by promoting the spread of resistant infections. This article examines the sources, occurrence, and spatial distribution of antibiotics and ARGs in Nigeria, highlighting the mechanisms of ARG transmission and the factors influencing their spread. Additionally, it discusses the human health risks and ecological impacts associated with antibiotic contamination, underscoring the urgent need for effective intervention strategies. Addressing these issues is also vital for achieving sustainable developments, particularly those related to health, clean water, and life below water. The review calls for advanced wastewater treatment, regulatory improvements, and increased public awareness to mitigate the impact of antibiotics and ARGs on Nigerian water systems.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1093/inteam/vjaf143
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.